Upgrade to SI Premium - Free Trial

FibroBiologics presents psoriasis data at dermatology meeting

May 22, 2026 8:30 AM
FibroBiologics Inc. (NASDAQ: FBLG) presented preclinical data for its CYPS317 psoriasis treatment program at the Society for Investigative Dermatology 2026 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA